HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Hayashi Selected Research

Osteoporosis

3/2010Effect of a prostaglandin EP4 receptor agonist on early fixation of hydroxyapatite/titanium composite- and titanium-coated rough-surfaced implants in ovariectomized rats.
11/2009Bone fragility in male glucocorticoid-induced osteoporosis is not defined by bone mineral density.
8/2009Inhibition of the mevalonate pathway rescues the dexamethasone-induced suppression of the mineralization in osteoblasts via enhancing bone morphogenetic protein-2 signal.
8/2005Prostaglandin EP4 receptor agonist augments fixation of hydroxyapatite-coated implants in a rat model of osteoporosis.
1/2000Differential effects of menopause and metabolic disease on trabecular and cortical bone assessed by peripheral quantitative computed tomography (pQCT).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K Hayashi Research Topics

Disease

31Neoplasms (Cancer)
08/2021 - 01/2000
10Infections
04/2018 - 08/2000
9Chronic Hepatitis C
04/2018 - 04/2000
9Hepatocellular Carcinoma (Hepatoma)
03/2004 - 01/2000
8Neoplasm Metastasis (Metastasis)
08/2011 - 01/2000
8Hypertension (High Blood Pressure)
04/2008 - 03/2000
7Proteinuria
04/2008 - 06/2000
6Carcinogenesis
08/2015 - 01/2000
6Glioma (Gliomas)
02/2010 - 09/2000
6Hyperplasia
11/2001 - 10/2000
5Pain (Aches)
11/2020 - 08/2000
5Fibrosis (Cirrhosis)
01/2018 - 09/2000
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2017 - 09/2001
5Carcinoma (Carcinomatosis)
06/2015 - 01/2000
5Necrosis
11/2012 - 04/2000
5Asthma (Bronchial Asthma)
11/2011 - 07/2000
5Atherosclerosis
01/2011 - 01/2001
5Osteoporosis
03/2010 - 01/2000
5Inflammation (Inflammations)
01/2007 - 01/2001
5Lymphoma (Lymphomas)
10/2003 - 01/2000
5Body Weight (Weight, Body)
10/2001 - 10/2000
4Wounds and Injuries (Trauma)
03/2021 - 10/2001
4Hypersensitivity (Allergy)
03/2015 - 04/2000
4Insulin Resistance
05/2014 - 10/2000
4Pathologic Constriction (Stenosis)
01/2011 - 08/2000
4Capsule Opacification
01/2010 - 06/2001
4Type 2 Diabetes Mellitus (MODY)
07/2006 - 09/2000
4Seizures (Absence Seizure)
06/2002 - 07/2000
4Glomerulonephritis
04/2001 - 07/2000
3Hyperalgesia
11/2020 - 08/2012
3Atopic Dermatitis (Atopic Eczema)
11/2019 - 02/2001
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2018 - 02/2008
3HIV Infections (HIV Infection)
01/2018 - 12/2000
3Virus Diseases (Viral Diseases)
01/2017 - 12/2000
3Dermatitis
09/2012 - 10/2001
3Chronic Renal Insufficiency
04/2012 - 04/2003
3Diabetes Mellitus
01/2011 - 12/2000
3Paralysis (Palsy)
02/2010 - 07/2006
3Sclerosis
05/2009 - 03/2000
3Esophageal Neoplasms (Esophageal Cancer)
01/2008 - 01/2004
3Pulmonary Edema
01/2007 - 11/2000
3Hepatitis C
01/2005 - 01/2000
3Aneurysm (Aneurysms)
09/2003 - 04/2001
3Hemorrhage
09/2003 - 11/2000
3Cardiomegaly (Heart Hypertrophy)
12/2001 - 12/2000
3Fatty Liver
12/2001 - 12/2000
3Herpetic Keratitis
10/2001 - 12/2000
3Hypertrophy
09/2001 - 06/2000
3Ischemia
08/2001 - 01/2000
3Breast Neoplasms (Breast Cancer)
06/2001 - 05/2000
3Astigmatism
10/2000 - 03/2000
2COVID-19
12/2022 - 03/2021
2Sarcoma (Soft Tissue Sarcoma)
08/2021 - 04/2014

Drug/Important Bio-Agent (IBA)

13DNA (Deoxyribonucleic Acid)IBA
07/2017 - 01/2000
12Proteins (Proteins, Gene)FDA Link
04/2003 - 01/2000
9InterferonsIBA
04/2018 - 08/2000
8Messenger RNA (mRNA)IBA
05/2013 - 01/2000
7AntigensIBA
11/2017 - 04/2000
7CytokinesIBA
09/2012 - 04/2000
6Glucose (Dextrose)FDA LinkGeneric
05/2014 - 10/2000
5Immunoglobulin E (IgE)IBA
03/2015 - 04/2000
5Immunoglobulin G (IgG)IBA
09/2012 - 12/2000
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2005 - 01/2000
5Antihypertensive Agents (Antihypertensives)IBA
12/2004 - 05/2000
5CollagenIBA
05/2003 - 04/2000
4Triglycerides (Triacylglycerol)IBA
04/2012 - 12/2000
4Cisplatin (Platino)FDA LinkGeneric
01/2011 - 07/2001
4CreatinineIBA
09/2008 - 09/2000
4CalciumIBA
12/2004 - 03/2000
4AutoantibodiesIBA
03/2002 - 08/2000
4SteroidsIBA
02/2002 - 01/2000
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2001 - 02/2000
3Oxygen (Dioxygen)IBA
03/2021 - 06/2000
3Indicators and Reagents (Reagents)IBA
01/2018 - 05/2004
3Estrogens (Estrogen)FDA Link
05/2015 - 12/2001
3Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
12/2004 - 11/2001
3Matrix Metalloproteinases (MMPs)IBA
01/2004 - 07/2000
3Adrenocorticotropic Hormone (ACTH)FDA Link
06/2002 - 11/2000
3ElementsIBA
11/2001 - 01/2001
3Fatty Acids (Saturated Fatty Acids)IBA
09/2001 - 01/2000
3Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
08/2001 - 01/2000
3Insulin (Novolin)FDA Link
05/2001 - 09/2000
3AlitretinoinFDA Link
01/2001 - 04/2000
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2022 - 01/2011
2Collagen Type II (Type II Collagen)IBA
01/2022 - 08/2002
2B7-H1 AntigenIBA
08/2021 - 07/2017
2Complement System Proteins (Complement)IBA
11/2018 - 02/2008
2Ribavirin (Virazole)FDA LinkGeneric
04/2018 - 09/2008

Therapy/Procedure

29Therapeutics
03/2021 - 01/2000
7Drug Therapy (Chemotherapy)
12/2020 - 07/2001
6Intraocular Lenses (Intraocular Lens)
01/2008 - 04/2000
4Chemoradiotherapy
01/2020 - 01/2004
4Esophagectomy
11/2017 - 09/2001
4Ligation
01/2010 - 01/2001
3Aftercare (After-Treatment)
08/2012 - 11/2000
3Transplantation
02/2010 - 04/2000
3Activities of Daily Living (ADL)
07/2006 - 03/2001
3Hepatectomy
10/2001 - 01/2000
3Laparotomy
08/2000 - 01/2000
2Immunotherapy
08/2021 - 10/2001